Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Mol Pharmacol
2012 Nov 01;825:795-802. doi: 10.1124/mol.112.079194.
Show Gene links
Show Anatomy links
Structure-activity relationship of fenamates as Slo2.1 channel activators.
Garg P, Sanguinetti MC.
???displayArticle.abstract???
Niflumic acid, 2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid (NFA), a nonsteroidal anti-inflammatory drug that blocks cyclooxygenase (COX), was shown previously to activate [Na(+)](i)-regulated Slo2.1 channels. In this study, we report that other fenamates, including flufenamic acid, mefenamic acid, tolfenamic acid, meclofenamic acid, and a phenyl acetic acid derivative, diclofenac, also are low-potency (EC(50) = 80 μM to 2.1 mM), partial agonists of human Slo2.1 channels heterologously expressed in Xenopus oocytes. Substituent analysis determined that N-phenylanthranilic acid was the minimal pharmacophore for fenamate activation of Slo2.1 channels. The effects of fenamates were biphasic, with an initial rapid activation phase followed by a slow phase of current inhibition. Ibuprofen, a structurally dissimilar COX inhibitor, did not activate Slo2.1. Preincubation of oocytes with ibuprofen did not significantly alter the effects of NFA, suggesting that neither channel activation nor inhibition is associated with COX activity. A point mutation (A278R) in the pore-lining S6 segment of Slo2.1 increased the sensitivity to activation and reduced the inhibition induced by NFA. Together, our results suggest that fenamates bind to two sites on Slo2.1 channels: an extracellular accessible site to activate and a cytoplasmic accessible site in the pore to inhibit currents.
Barnett,
Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.
1994, Pubmed
Barnett,
Purification, characterization and selective inhibition of human prostaglandin G/H synthase 1 and 2 expressed in the baculovirus system.
1994,
Pubmed Bhattacharjee,
Slick (Slo2.1), a rapidly-gating sodium-activated potassium channel inhibited by ATP.
2003,
Pubmed
,
Xenbase Busch,
Positive regulation by chloride channel blockers of IsK channels expressed in Xenopus oocytes.
1994,
Pubmed
,
Xenbase Dai,
Activation of Slo2.1 channels by niflumic acid.
2010,
Pubmed
,
Xenbase Dhanaraj,
Structural studies of analgesics and their interactions. XII. Structure and interactions of anti-inflammatory fenamates. A concerted crystallographic and theoretical conformational study.
1988,
Pubmed Farrugia,
Potassium current in circular smooth muscle of human jejunum activated by fenamates.
1993,
Pubmed Fernandez,
Structural basis for ether-a-go-go-related gene K+ channel subtype-dependent activation by niflumic acid.
2008,
Pubmed
,
Xenbase Flower,
Effects of anti-inflammatory drugs on prostaglandin biosynthesis.
1972,
Pubmed Gögelein,
Flufenamic acid, mefenamic acid and niflumic acid inhibit single nonselective cation channels in the rat exocrine pancreas.
1990,
Pubmed Greenwood,
Comparison of the effects of fenamates on Ca-activated chloride and potassium currents in rabbit portal vein smooth muscle cells.
1995,
Pubmed Gribkoff,
Effects of channel modulators on cloned large-conductance calcium-activated potassium channels.
1996,
Pubmed
,
Xenbase Grover,
The cardioprotective and electrophysiological effects of cromakalim are attenuated by meclofenamate through a cyclooxygenase-independent mechanism.
1994,
Pubmed Jiang,
Effect of non-steroidal anti-inflammatory drugs and new fenamate analogues on TRPC4 and TRPC5 channels.
2012,
Pubmed Kameyama,
Intracellular Na+ activates a K+ channel in mammalian cardiac cells.
,
Pubmed Liantonio,
Molecular switch for CLC-K Cl- channel block/activation: optimal pharmacophoric requirements towards high-affinity ligands.
2008,
Pubmed
,
Xenbase Liantonio,
Activation and inhibition of kidney CLC-K chloride channels by fenamates.
2006,
Pubmed
,
Xenbase Malykhina,
Fenamate-induced enhancement of heterologously expressed HERG currents in Xenopus oocytes.
2002,
Pubmed
,
Xenbase Ottolia,
Potentiation of large conductance KCa channels by niflumic, flufenamic, and mefenamic acids.
1994,
Pubmed Peretz,
Meclofenamic acid and diclofenac, novel templates of KCNQ2/Q3 potassium channel openers, depress cortical neuron activity and exhibit anticonvulsant properties.
2005,
Pubmed Sanger,
Fenamates may antagonize the actions of prostaglandin endoperoxides in human myometrium.
1979,
Pubmed Santi,
Opposite regulation of Slick and Slack K+ channels by neuromodulators.
2006,
Pubmed
,
Xenbase Schreibmayer,
Voltage clamping of Xenopus laevis oocytes utilizing agarose-cushion electrodes.
1994,
Pubmed
,
Xenbase Stühmer,
Electrophysiological recording from Xenopus oocytes.
1992,
Pubmed
,
Xenbase Wang,
Conductance properties of the Na(+)-activated K+ channel in guinea-pig ventricular cells.
1991,
Pubmed Wang,
Unexpected and differential effects of Cl- channel blockers on the Kv4.3 and Kv4.2 K+ channels. Implications for the study of the I(to2) current.
1997,
Pubmed
,
Xenbase White,
Niflumic and flufenamic acids are potent reversible blockers of Ca2(+)-activated Cl- channels in Xenopus oocytes.
1990,
Pubmed
,
Xenbase Wiemuth,
The pharmacological profile of brain liver intestine Na+ channel: inhibition by diarylamidines and activation by fenamates.
2011,
Pubmed
,
Xenbase Yuan,
The sodium-activated potassium channel is encoded by a member of the Slo gene family.
2003,
Pubmed
,
Xenbase
